Cocaine vaccines: Antibody protection against relapse in a rat model

Proceedings of the National Academy of Sciences of the United States of America

Volumn 97, Issue 11, 2000, Pages 6202-6206

  Carrera, M Rocio A ^a   Ashley, Jon A ^a   Zhou, Bin ^a   Wirsching, Peter ^a   Koob, George F ^a   Janda, Kim D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; COCAINE; GNC92H2; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; KEYHOLE LIMPET HEMOCYANIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE; DRUG SELF ADMINISTRATION; EXPERIMENTAL MODEL; MALE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RAT; RELAPSE; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; COCAINE; COCAINE-RELATED DISORDERS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HEMOCYANIN; IMMUNIZATION; IMMUNIZATION, PASSIVE; MALE; RATS; RATS, WISTAR; RECURRENCE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; VACCINATION; VACCINES;

EID: 0034705038     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.97.11.6202     Document Type: Article

References (32)

1. National Institute on Drug Abuse (1996) National Household Survey on Drug Abuse, Population Estimates (1995) (U.S. Dept. of Health and Human Services, Rockville, MD).
2. Cregler, L. L. & Mark, H. (1986) N. Engl. J. Med. 315, 1495-1500.
3. Lee, J. H. & Bennett, G. (1991) in Substance Abuse: Pharmacologic, Developmental and Clinical Perspectives, eds. Bennett, G. & Wolf, D. (Delman, New York), pp. 157-170.
4. Carrol, F. I., Lewin, A. & Biswas, J. (1994) Pharmacol. News 1, 11-16.
5. Carrera, M. R. A., Ashley, J. A., Parsons, L. H., Wirsching, P., Koob, G. F. & Janda, K. D. (1995) Nature (London) 378, 727-730.
6. Basagra, O., Forman, L. J., Howeedy, A. & Whittle, P. A. (1992) Immunopharmacology 23, 143-179.
7. Fox, B. S., Kantak, K. M., Edwards, M. A., Black, K. M., Bollinger, B. K., Botka, A. J., French, T. L., Thompson, T. L., Schad, V. C., Greenstein, J. L., et al. (1996) Nat. Med. 2, 1129-1132.
8. Ettinger, R. H., Ettinger, W. F. & Harless, W. E. (1997) Pharmacol. Biochem. Behav. 58, 215-220.
9. Gallacher, G. (1994) Immunopharmacology 27, 79-81.
10. Self, D. W. (1995) Nature (London) 378, 666-667.
11. Wise, R. A. & Rinaldi, R. (1996) Nat. Med. 2, 1073-1074.
12. Jaffe, J. H. (1989) in The Pharmacological Basis of Therapeutics, eds. Gilman, A. G., Rall, T. W., Nies, A. S. & Taylor, P. (Goodman and Gilman's, New York), pp. 522-573.
13. Kosten, T. R. (1990) J. Nerv. Ment. Dis. 13, 176-217.
14. Ludwig, A. M., Wikler, A. & Stark, L. H. (1974) Arch. Gen. Psychiatry 30, 539-547.
15. Gerber, G. J. & Stretch, R. (1975) Pharmacol. Biochem. Behav. 3, 1055-1061.
16. de Wit, H. & Stewart, J. (1981) Psychopharmacology 75, 134-143.
17. de Wit, H. & Stewart, J. (1983) Psychopharmacology 79, 29-31.
18. Stewart, J. & de Wit, H. (1987) in Methods of Assessing the Reinforcing Properties of Abused Drugs, ed. Bozarth, M. A. (Springer, New York), pp. 211-227.
19. Shaham, Y., Rodaros, D. & Stewart, J. (1994) Behav. Pharmacol. 5, 360-364.
20. de Wit, H. & Wise, R. A. (1977) Can. J. Psychol. 31, 195-203.
21. Koob, G. F., Le, H. T. & Creese, I. (1987) Neurosci. Lett. 79, 315-320.
22. Bergman, J., Kamien, J. B. & Spealman, R. D. (1990) Behav. Pharmacol. 1, 355-363.
23. Woolverton, W. L. & Virus, R. M. (1989) Pharmacol. Biochem. Behav. 32, 691-697.
24. Caine, S. B., Lintz, R. & Koob, G. F. (1993) in Behavioral Neuroscience: A Practical Approach, ed. Shagal, A. (Oxford Univ. Press, Oxford), pp. 117-143.
25. Köhler, G., Howe, S. C. & Milstein, C. (1976) Eur. J. Immunol. 6, 292-295.
26. Köhler, G. & Milstein, C. (1976) Eur. J. Immunol. 6, 511-519.
27. Pickens, R. & Thompson, T. (1968) J. Pharmacol. Exp. Ther. 161, 122-129.
28. Wilson, M. C., Hitomi, M. & Schuster, C. R. (1971) Psychopharmacologia 22, 271-281.
29. Wilson, M. C. & Schuster, C. R. (1972) Psychopharmacologia 26, 84-99.
30. Jaffe, J. H., Cascella, N. G., Kumor, K. M. & Sherer, M. A. (1989) Psychopharmacology 97, 59-64.
31. McKay, J. R., Rutherford, M. J., Alterman, A. I., Cacciola, J. S. & Kaplan, M. R. (1995) Drug Alcohol Depend. 38, 35-43.
32. Rohsenow, D. J., Childress, A. R., Monti, P. M., Niaura, R. S. & Abrams, D. B. (1990-1991) Int. J. Addict. 25, 956-993.